
Paramagnetic contrast media for magnetic resonance imaging of the mediastinum and lungs
Author(s) -
Denis H. Carr
Publication year - 1985
Publication title -
journal of thoracic imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.836
H-Index - 57
eISSN - 1536-0237
pISSN - 0883-5993
DOI - 10.1097/00005382-198512000-00010
Subject(s) - medicine , mediastinum , magnetic resonance imaging , gadolinium , lung , contrast (vision) , radiology , thorax (insect anatomy) , paramagnetism , intravenous contrast , parenchyma , pathology , nuclear medicine , computed tomography , anatomy , materials science , physics , quantum mechanics , artificial intelligence , metallurgy , computer science
The use of paramagnetic contrast agents in magnetic resonance imaging (MRI) of the lungs and mediastinum has been the subject of preliminary investigation. Gadolinium-DTPA (Gd3+-DTPA) is a suitable intravenous paramagnetic contrast agent for imaging cerebral tumors and liver tumors. Its use in the thorax is more speculative, but early animal experimental data suggest that contrast-enhanced MRI may have a place in the assessment of pulmonary edema and lung parenchymal damage.